(Q44235754)

English

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

scientific article published in October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

Licia Rivoltini

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Scheibenbogen C

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Romero P

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Herr W

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Schmittel A

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Cerottini JC

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Woelfel T

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Eggermont AM

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Keilholz U

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 October 2000

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

244

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

81-89

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Rapid effector function in CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Quantification of tumor-specific T lymphocytes with the ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900257-X

7 January 2021

Identifiers

10.1016/S0022-1759(00)00257-X

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44235754&oldid=2108824614"